ADPT Financials
Adaptive Biotechnologies Corp - Financial statements & key metrics
Stock Price
$17.87
Market Cap
$2.73B
EPS
$-0.52
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$178.96M
Gross Profit
-
Operating Income
-
Net Income
$-159.59M
EPS (Diluted)
$-1.08
Balance Sheet Highlights
Total Assets
$539.38M
Total Liabilities
$336.89M
Shareholders Equity
-
Cash & Equivalents
$47.92M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-95.21M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
65.1%
Operating Margin
0.1%
Net Margin
-0.3%
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ADPT revenue?
ADPT's most recent quarterly revenue was $178.96M. Annual revenue can be calculated by summing the four most recent quarters.
Is ADPT profitable?
ADPT reported a loss of $159.59M in the most recent quarter. The net profit margin is -0.3%.
What is ADPT market cap?
ADPT has a market capitalization of $2.73B, making it a mid-cap stock.
Does ADPT have debt?
View ADPT's balance sheet for debt information.
What is ADPT cash flow?
Cash flow data is available in the full financial statements.